This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WIRB-Copernicus Group Announces Release Of IRBNet National Research Network® 2012 Benchmark Report

"Institutions large and small struggle with the challenge of maintaining the financial viability of their research programs," said Stuart Horowitz, Ph.D., President of Institutions & Institutional Services at WIRB-Copernicus Group. "Although there are several means by which institutions can address this challenge, they must first independently and objectively assess their performance and position in the research market. The IRBNet National Research Network Benchmark Report is the only available source of data to help them to do that."

Download the IRBNet National Research Network 2012 Benchmark Report at:

About IRBNet A WIRB-Copernicus Group Company

IRBNet offers the world's most widely used electronic solution for managing research compliance for institutions of any size, with more than 1,700 large, medium and small research institutions, boards and research sites registered on the National Research Network®. National Research Network® members benefit from secure online access to comprehensive research oversight tools anywhere, anytime, including real-time collaboration between investigators and institutions anywhere in the world. The National Research Network Enterprise Portal further enables institutions to navigate the complex federal ethics compliance requirements governing human, animal, and recombinant DNA research, while seamlessly managing Conflict of Interest, Sponsored Programs and other critical research oversight activities. With the release of the National Research Network 2012 Benchmark Report, IRBNet's unparalleled data-driven performance metrics make it easier than ever for universities and colleges, community hospitals, hospital networks, and federal and state agencies to benchmark internal performance and drive process improvement across multiple sites and complex organizational systems. For further information on IRBNet, please visit

IRBNet and National Research Network are marks of Research Dataware, LLC. All rights are reserved and no use of the marks are permitted without the express written consent of Research Dataware, LLC.

About WIRB-Copernicus Group The nation's leading independent institutional review boards (IRB's) are united to provide a comprehensive ethical review solution to sponsors, CROs and institutions. Guided by a team of ethical and regulatory experts, WIRB-Copernicus Group deploys decades of experience and best-practices in protocol compliance, operational excellence, financial performance and overall efficiency. With more than 60 years of combined experience reviewing research protocols and study-related information, it is the mission of WIRB-Copernicus Group to meet the highest standards of ethics and science, and to ensure the safety and welfare of subjects worldwide. For more information, visit



Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs